Advertisement

Topics

Inhibition of NOX2 is a novel strategy to reduce the burden of malignant cells in CML

05:46 EDT 8 Aug 2017 | ecancermedicalscience

In the British Journal of Haematology, researchers show that the genetic elimination of NOX2 function delayed the development of CML in mice and prolonged survival. In the US, there are approximately 100,000 patients living with CML. The patients...

Original Article: Inhibition of NOX2 is a novel strategy to reduce the burden of malignant cells in CML

NEXT ARTICLE

More From BioPortfolio on "Inhibition of NOX2 is a novel strategy to reduce the burden of malignant cells in CML"

Quick Search
Advertisement